A Mæland

761 total citations
23 papers, 407 citations indexed

About

A Mæland is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, A Mæland has authored 23 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 10 papers in Hepatology and 6 papers in Infectious Diseases. Recurrent topics in A Mæland's work include Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (9 papers) and Liver Disease Diagnosis and Treatment (8 papers). A Mæland is often cited by papers focused on Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (9 papers) and Liver Disease Diagnosis and Treatment (8 papers). A Mæland collaborates with scholars based in Norway, Denmark and United Kingdom. A Mæland's co-authors include Per Sandven, A. Bjørneklett, Kjell Skaug, Per Sandvei, N Raknerud, Kjell B. Hellum, H. Bell, Zbigniew Konopski, Kristian Bjøro and Jan Kristian Damås and has published in prestigious journals such as The Lancet, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

A Mæland

21 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Mæland Norway 10 298 270 117 33 31 23 407
D. Genovese Italy 16 260 0.9× 244 0.9× 192 1.6× 11 0.3× 25 0.8× 23 489
M.H. Elghouzzi France 11 215 0.7× 170 0.6× 33 0.3× 8 0.2× 62 2.0× 23 305
María Luisa Mateos Spain 12 270 0.9× 368 1.4× 190 1.6× 12 0.4× 11 0.4× 19 477
Tatjana Tallo Estonia 9 201 0.7× 254 0.9× 100 0.9× 5 0.2× 29 0.9× 21 310
Tonya Hayden United States 8 172 0.6× 198 0.7× 42 0.4× 8 0.2× 90 2.9× 12 327
Leopoldo Deibis Venezuela 9 115 0.4× 96 0.4× 195 1.7× 12 0.4× 24 0.8× 19 419
Romy Weller Germany 5 75 0.3× 78 0.3× 105 0.9× 21 0.6× 92 3.0× 6 221
Verónica Saludes Spain 15 338 1.1× 334 1.2× 105 0.9× 7 0.2× 15 0.5× 38 527
Richard B. Capps United States 7 274 0.9× 262 1.0× 97 0.8× 27 0.8× 16 0.5× 9 428

Countries citing papers authored by A Mæland

Since Specialization
Citations

This map shows the geographic impact of A Mæland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Mæland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Mæland more than expected).

Fields of papers citing papers by A Mæland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Mæland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Mæland. The network helps show where A Mæland may publish in the future.

Co-authorship network of co-authors of A Mæland

This figure shows the co-authorship network connecting the top 25 collaborators of A Mæland. A scholar is included among the top collaborators of A Mæland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Mæland. A Mæland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwartz, Thomas, Mogens Jensenius, Bjørn Blomberg, et al.. (2019). Imported visceral leishmaniasis and immunosuppression in seven Norwegian patients. Tropical Diseases Travel Medicine and Vaccines. 5(1). 16–16. 9 indexed citations
2.
Midgard, Håvard, A Mæland, Zbigniew Konopski, et al.. (2016). Hepatitis C reinfection after sustained virological response. Journal of Hepatology. 64(5). 1020–1026. 104 indexed citations
3.
Kran, Anne‐Marte Bakken, Tom Øystein Jonassen, Mette Sannes, et al.. (2009). Overestimation of Human Immunodeficiency Virus Type 1 Load Caused by the Presence of Cells in Plasma from Plasma Preparation Tubes. Journal of Clinical Microbiology. 47(7). 2170–2174. 15 indexed citations
4.
Jensenius, Mogens, et al.. (2007). Extensive hookworm-related cutaneous larva migrans in Norwegian travellers to the tropics. Travel Medicine and Infectious Disease. 6(1-2). 45–47. 3 indexed citations
5.
Bruun, Johan N., et al.. (2007). Fra dødelig syndrom til kronisk sykdom. ˜Den œNorske tannlegeforenings tidende. 117(2). 102–6–102–6.
6.
Skeie, Linda Gail & A Mæland. (2006). Can efavirenz be taken in the morning?. Scandinavian Journal of Infectious Diseases. 38(11-12). 1089–1091. 3 indexed citations
7.
Bruun, Johan N., et al.. (2006). [HIV/AIDS--from lethal syndrome to chronic disease].. PubMed. 126(23). 3121–4. 3 indexed citations
8.
Bjøro, Kristian, H. Bell, Kjell B. Hellum, et al.. (2002). Effect of Combined Interferon-α Induction Therapy and Ribavirin on Chronic Hepatitis C Virus Infection: a Randomized Multicentre Study. Scandinavian Journal of Gastroenterology. 37(2). 226–232. 59 indexed citations
9.
Jensenius, Mogens, et al.. (1997). Q-feber importert til Norge. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
10.
Bell, Helge, Kjell B. Hellum, Stig Harthug, et al.. (1997). Genotype, Viral Load and Age as Independent Predictors of Treatment Outcome of Interferon-α2a Treatment in Patients with Chronic Hepatitis C. Scandinavian Journal of Infectious Diseases. 29(1). 17–22. 46 indexed citations
11.
Jensenius, Mogens, A Mæland, & Sirkka Vene. (1997). [Endemic typhus imported to Norway].. PubMed. 117(17). 2447–9. 2 indexed citations
12.
Nordøy, Ingvild, Henrik Krarup, H. Bell, et al.. (1997). Interferon-α2b Therapy in Low-Activity Hepatitis C: A Pilot Study. Scandinavian Journal of Gastroenterology. 32(12). 1256–1260. 17 indexed citations
13.
Jensenius, Mogens, et al.. (1997). [Q-fever imported into Norway].. PubMed. 117(27). 3937–40. 3 indexed citations
14.
Bell, Helge, Kjell B. Hellum, Stig Harthug, et al.. (1996). Prevalence of Hepatitis C Genotypes among Patients with Chronic Hepatitis C in Norway. Scandinavian Journal of Infectious Diseases. 28(4). 357–359. 15 indexed citations
15.
Bjøro, Kristian, Henrik Krarup, H. Bell, et al.. (1995). Two Dose Regimens of Recombinant Interferon-Alpha-2b in Chronic Hepatitis C Virus Infection: Biochemistry, Hepatitis C Virus RNA, and Liver Histology as Response Indices. Scandinavian Journal of Gastroenterology. 30(11). 1119–1124. 10 indexed citations
16.
Sandven, Per, A. Bjørneklett, & A Mæland. (1993). Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group. Antimicrobial Agents and Chemotherapy. 37(11). 2443–2448. 79 indexed citations
17.
Skaug, Kjell, et al.. (1992). Second‐Generation Anti‐HCV Tests Predict Infectivity. Vox Sanguinis. 63(1). 39–42. 15 indexed citations
18.
Skaug, Kjell, et al.. (1991). Infective, chronic carriers of Hepatitis C virus among blood donors with no history of clinical hepatitis. Transfusion Medicine. 1(1). 13–16. 3 indexed citations
19.
Mæland, A, et al.. (1989). REACTIVATION OF HEPATITIS B. The Lancet. 333(8646). 1083–1084. 7 indexed citations
20.
Bruun, Johan N., Asbjørn Digranes, Johs. Bøe, & A Mæland. (1983). Treatment of Salmonella Carriers with Pivmecillinam Alone or in Combination with Pivampicillin: Experience with Three Patients. Scandinavian Journal of Infectious Diseases. 15(1). 21–24. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026